The pharmaceutical industry is a cornerstone of modern healthcare, providing innovative solutions to an array of medical challenges. The journey from a…
Efficient, comprehensive transitions from early phase (preclinical up to phase 1) to late phase (phase 2 and beyond) are critical to the…
If scientific literature indicates that elements are not likely to be present in drug product components, and no additional elements are added…
“New drugs receiving expedited approval have shorter timelines, which can create unique challenges for development and manufacturing. Joe Dukich, director of operations…
Characterizing an API’s different salt forms and polymorphs is an essential drug development task. The successful preclinical assessment and product development can…